Ried Karin, Travica Nikolaj, Sali Avni
National Institute of Integrative Medicine, Melbourne, Australia; Faculty of Health Science and Medicine, Bond University, Gold Coast, Australia; Department of General Practice, University of Adelaide, Adelaide, Australia.
National Institute of Integrative Medicine, Melbourne, Australia.
Integr Blood Press Control. 2016 Jan 27;9:9-21. doi: 10.2147/IBPC.S93335. eCollection 2016.
Hypertension affects 30% of adults worldwide. Garlic supplements have shown promise in the treatment of uncontrolled hypertension, and the mechanism of action is biologically plausible. Our trial is the first to assess the effect of aged garlic extract on central blood pressure and arterial stiffness, regarded as important risk factors for cardiovascular morbidity.
A total of 88 general practice patients and community members with uncontrolled hypertension completed a double-blind randomized placebo-controlled trial of 12 weeks investigating the effect of daily intake of aged garlic extract (1.2 g containing 1.2 mg S-allylcysteine) or placebo on blood pressure, and secondary outcome measures of central-hemodynamics and other cardiovascular markers, including cholesterol, homocysteine, platelet function, and inflammatory markers.
Mean blood pressure was significantly reduced by 5.0±2.1 mmHg (P=0.016) systolic, and in responders by 11.5±1.9 mmHg systolic and 6.3±1.1 mmHg diastolic compared to placebo (P<0.001). Central hemodynamic-measures tended to improve in the garlic group more than in the placebo group, including central blood pressure, central pulse pressure, mean arterial pressure, augmentation pressure, pulse-wave velocity, and arterial stiffness. While changes in other cardiovascular markers did not reach significance due to small numbers in subgroups with elevated levels, trends in beneficial effects of garlic on the inflammatory markers TNFα, total cholesterol, low-density lipid cholesterol, and apolipoproteins were observed. Aged garlic extract was highly tolerable and acceptable, and did not increase the risk of bleeding in patients on blood-thinning medication.
Our trial suggests that aged garlic extract is effective in reducing peripheral and central blood pressure in a large proportion of patients with uncontrolled hypertension, and has the potential to improve arterial stiffness, inflammation, and other cardiovascular markers in patients with elevated levels. Aged garlic extract was highly tolerable with a high safety profile as a stand-alone or adjunctive antihypertensive treatment.
高血压影响着全球30%的成年人。大蒜补充剂在治疗未控制的高血压方面显示出前景,其作用机制在生物学上是合理的。我们的试验是首个评估 aged garlic extract(AGE)对中心血压和动脉僵硬度影响的试验,而中心血压和动脉僵硬度被视为心血管疾病发病的重要危险因素。
共有88名患有未控制高血压的全科医疗患者和社区成员完成了一项为期12周的双盲随机安慰剂对照试验,该试验研究每日摄入aged garlic extract(1.2克,含1.2毫克S - 烯丙基半胱氨酸)或安慰剂对血压的影响,以及中心血流动力学和其他心血管标志物的次要结局指标,包括胆固醇、同型半胱氨酸、血小板功能和炎症标志物。
与安慰剂相比,收缩压平均显著降低5.0±2.1 mmHg(P = 0.016),在有反应者中,收缩压降低11.5±1.9 mmHg,舒张压降低6.3±1.1 mmHg(P < 0.001)。大蒜组的中心血流动力学指标改善趋势比安慰剂组更明显,包括中心血压、中心脉压、平均动脉压、增压、脉搏波速度和动脉僵硬度。虽然由于水平升高亚组中的样本量较小,其他心血管标志物的变化未达到显著水平,但观察到大蒜对炎症标志物TNFα、总胆固醇、低密度脂蛋白胆固醇和载脂蛋白的有益作用趋势。Aged garlic extract耐受性良好且可接受,并且不会增加正在服用血液稀释药物患者的出血风险。
我们的试验表明,aged garlic extract对很大一部分未控制高血压患者降低外周和中心血压有效,并且有可能改善水平升高患者的动脉僵硬度、炎症和其他心血管标志物。Aged garlic extract作为单一或辅助抗高血压治疗具有高度耐受性和高安全性。